Cargando…
Edoxaban Dosing Time Affects Blood Coagulation Inhibition in Rats
Coagulation–fibrinolytic system activity shows daily rhythmicity, with hypercoagulability in the morning and hypocoagulability in the evening. Consequently, the efficacy of anticoagulants may be influenced by their dosing time. Edoxaban, a selective inhibitor of the active form of coagulation factor...
Autores principales: | Nagata, Naoto, Kawasumi, Muneo, Fujimura, Akio, Ando, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046513/ https://www.ncbi.nlm.nih.gov/pubmed/33870074 http://dx.doi.org/10.1055/s-0041-1725041 |
Ejemplares similares
-
Point-of-care testing of coagulation in patients treated with edoxaban
por: Härtig, Florian, et al.
Publicado: (2020) -
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021) -
Chronic Treatment with Metformin Has No Disrupting Effect on the Hepatic Circadian Clock in Mice
por: Hasan, Nazmul, et al.
Publicado: (2022) -
The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma
por: Siriez, Romain, et al.
Publicado: (2022) -
Successful Treatment with Edoxaban for Disseminated Intravascular Coagulation in a Case of Aortic Dissection Complicated with Immune Thrombocytopenic Purpura
por: Uemura, Shun, et al.
Publicado: (2020)